Monthly Review Online — Cuba continues to make major strides in medical research and development in spite of the U.S.-imposed blockade and the challenges it poses, including in the case of the Matanzas fire. In addition to the three approved, home-grown, COVID-19 vaccines, Cuban scientists have made progress with other treatments for other diseases as well. One of them is NeuralCIM–a neuroprotective drug showing positive results among patients suffering from Alzheimer’s, Parkinson’s, and ataxia. The drug is entering advanced phases… — Read More —
Join us for our Monthly Meetings!
We are currently meeting via Zoom. Meetings are generally held every 2nd Tuesday of the month at 7:00 PM. Email us at email@example.com for the link to attend.